Altoida Awarded FDA Breakthrough Designation for Development of World s First Precision Neurology Device for Prediction of Alzheimer s Disease prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
Diadem Awarded Patent in China for Its AlzoSure® Prognostic Biomarker Technology that Accurately Predicts Progression to Alzheimer s Disease biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
Do We All Have Alzheimerâs? Drug Makers Might Want You to Think So
July 30, 2021
From
The Baltimore Sun: “This month, the Food and Drug Administration changed the label for the recently approved Alzheimerâs treatment aducanumab â sold under the brand name ‘Aduhelm’ â to specify that the controversial drug made by U.S. biotech company Biogen should be used only by patients with mild dementia or mild cognitive impairment. This should be no bar to widespread use, however, as recent efforts indicate that Biogen may be trying to persuade adults who occasionally misplace their keys that they not only have Mild Cognitive Impairment (MCI), but that MCI is an early form of